IMGT Co.,Ltd. (XKON:456570)

South Korea flag South Korea · Delayed Price · Currency is KRW
14,900
-230 (-1.52%)
At close: Apr 23, 2026
Market Cap78.37B +24.9%
Revenue (ttm)102.33M +7,832.6%
Net Income731.32M
EPS812.00
Shares Out5.26M
PE Ratio18.36
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,019
Average Volume3,349
Open15,110
Previous Close15,130
Day's Range14,100 - 15,110
52-Week Range8,690 - 28,000
Beta1.54
RSI49.92
Earnings Daten/a

About IMGT Co.,Ltd.

IMGT Co.,Ltd. engages in researching and developing of an ultrasound-guided therapy technology for genetic therapy and drug delivery systems. It develops IMGT-LPS, a technology that injects ultrasound-sensitive nanoparticles in the form of liposome-wrapped pharmacological substances into the body and releases drugs by irradiating ultrasound to the target area(tumor); IMGT-EMB, a nanoparticle for chemoembolization of liver cancer; IMGT-TSD, a targeted sonodynamic therapy that induces immune boosting mechanism by applying ultrasonic stimulation t... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2010
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 456570
Full Company Profile